290 related articles for article (PubMed ID: 8602220)
1. Inhibition of monoamine oxidase B in the brains of smokers.
Fowler JS; Volkow ND; Wang GJ; Pappas N; Logan J; MacGregor R; Alexoff D; Shea C; Schlyer D; Wolf AP; Warner D; Zezulkova I; Cilento R
Nature; 1996 Feb; 379(6567):733-6. PubMed ID: 8602220
[TBL] [Abstract][Full Text] [Related]
2. Neuropharmacological actions of cigarette smoke: brain monoamine oxidase B (MAO B) inhibition.
Fowler JS; Volkow ND; Wang GJ; Pappas N; Logan J; MacGregor R; Alexoff D; Wolf AP; Warner D; Cilento R; Zezulkova I
J Addict Dis; 1998; 17(1):23-34. PubMed ID: 9549600
[TBL] [Abstract][Full Text] [Related]
3. Platelet monoamine oxidase, smoking cessation, and tobacco withdrawal symptoms.
Rose JE; Behm FM; Ramsey C; Ritchie JC
Nicotine Tob Res; 2001 Nov; 3(4):383-90. PubMed ID: 11694206
[TBL] [Abstract][Full Text] [Related]
4. Human monoamine oxidase is inhibited by tobacco smoke: beta-carboline alkaloids act as potent and reversible inhibitors.
Herraiz T; Chaparro C
Biochem Biophys Res Commun; 2005 Jan; 326(2):378-86. PubMed ID: 15582589
[TBL] [Abstract][Full Text] [Related]
5. Isolation and characterization of a monoamine oxidase B selective inhibitor from tobacco smoke.
Khalil AA; Davies B; Castagnoli N
Bioorg Med Chem; 2006 May; 14(10):3392-8. PubMed ID: 16458520
[TBL] [Abstract][Full Text] [Related]
6. Tobacco leaf, smoke and smoking, MAO inhibitors, Parkinson's disease and neuroprotection; are there links?
Castagnoli K; Murugesan T
Neurotoxicology; 2004 Jan; 25(1-2):279-91. PubMed ID: 14697903
[TBL] [Abstract][Full Text] [Related]
7. Monoamine oxidase A rather than monoamine oxidase B inhibition increases nicotine reinforcement in rats.
Guillem K; Vouillac C; Azar MR; Parsons LH; Koob GF; Cador M; Stinus L
Eur J Neurosci; 2006 Dec; 24(12):3532-40. PubMed ID: 17229101
[TBL] [Abstract][Full Text] [Related]
8. Contribution of monoamine oxidase (MAO) inhibition to tobacco and alcohol addiction.
van Amsterdam J; Talhout R; Vleeming W; Opperhuizen A
Life Sci; 2006 Oct; 79(21):1969-73. PubMed ID: 16884739
[TBL] [Abstract][Full Text] [Related]
9. Evidence for reduced arterial plasma input, prolonged lung retention and reduced lung monoamine oxidase in smokers.
Logan J; Fowler JS
Nucl Med Biol; 2005 Jul; 32(5):521-9. PubMed ID: 15982583
[TBL] [Abstract][Full Text] [Related]
10. Hydrogen peroxide enhances the activity of monoamine oxidase type-B but not of type-A: a pilot study.
Konradi C; Riederer P; Youdim MB
J Neural Transm Suppl; 1986; 22():61-73. PubMed ID: 3097261
[TBL] [Abstract][Full Text] [Related]
11. Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases.
Youdim MB; Fridkin M; Zheng H
Mech Ageing Dev; 2005 Feb; 126(2):317-26. PubMed ID: 15621213
[TBL] [Abstract][Full Text] [Related]
12. Relationships between effects of smoking, gender, and alcohol dependence on platelet monoamine oxidase-B: activity, affinity labeling, and protein measurements.
Snell LD; Glanz J; Tabakoff B;
Alcohol Clin Exp Res; 2002 Jul; 26(7):1105-13. PubMed ID: 12170121
[TBL] [Abstract][Full Text] [Related]
13. Effects of selegiline (L-deprenyl) during smoking and short-term abstinence.
Houtsmuller EJ; Thornton JA; Stitzer ML
Psychopharmacology (Berl); 2002 Sep; 163(2):213-20. PubMed ID: 12202968
[TBL] [Abstract][Full Text] [Related]
14. Genotype combinations for monoamine oxidase-B intron 13 polymorphism and dopamine D2 receptor TaqIB polymorphism are associated with ever-smoking status among men.
Costa-Mallen P; Costa LG; Checkoway H
Neurosci Lett; 2005 Sep; 385(2):158-62. PubMed ID: 15955630
[TBL] [Abstract][Full Text] [Related]
15. Assessment of MAO-B occupancy in the brain with PET and [11C]-L-deprenyl-D2: a dose-finding study with a novel MAO-B inhibitor, EVT 301.
Hirvonen J; Kailajärvi M; Haltia T; Koskimies S; Någren K; Virsu P; Oikonen V; Sipilä H; Ruokoniemi P; Virtanen K; Scheinin M; Rinne JO
Clin Pharmacol Ther; 2009 May; 85(5):506-12. PubMed ID: 19129751
[TBL] [Abstract][Full Text] [Related]
16. An acute dose of nicotine does not inhibit MAO B in baboon brain in vivo.
Fowler JS; Volkow ND; Logan J; Pappas N; King P; MacGregor R; Shea C; Garza V; Gatley SJ
Life Sci; 1998; 63(2):PL19-23. PubMed ID: 9674950
[TBL] [Abstract][Full Text] [Related]
17. Smoking a single cigarette does not produce a measurable reduction in brain MAO B in non-smokers.
Fowler JS; Wang GJ; Volkow ND; Franceschi D; Logan J; Pappas N; Shea C; MacGregor RR; Garza V
Nicotine Tob Res; 1999 Dec; 1(4):325-9. PubMed ID: 11072429
[TBL] [Abstract][Full Text] [Related]
18. Low monoamine oxidase B in peripheral organs in smokers.
Fowler JS; Logan J; Wang GJ; Volkow ND; Telang F; Zhu W; Franceschi D; Pappas N; Ferrieri R; Shea C; Garza V; Xu Y; Schlyer D; Gatley SJ; Ding YS; Alexoff D; Warner D; Netusil N; Carter P; Jayne M; King P; Vaska P
Proc Natl Acad Sci U S A; 2003 Sep; 100(20):11600-5. PubMed ID: 12972641
[TBL] [Abstract][Full Text] [Related]
19. Striatal 6-[18F]fluorodopa accumulation after combined inhibition of peripheral catechol-O-methyltransferase and monoamine oxidase type B: differing response in relation to presynaptic dopaminergic dysfunction.
Ruottinen HM; Rinne JO; Oikonen VJ; Bergman JR; Haaparanta MT; Solin OH; Ruotsalainen UH; Rinne UK
Synapse; 1997 Dec; 27(4):336-46. PubMed ID: 9372556
[TBL] [Abstract][Full Text] [Related]
20. Biological aspects of the link between smoking and depression.
Quattrocki E; Baird A; Yurgelun-Todd D
Harv Rev Psychiatry; 2000 Sep; 8(3):99-110. PubMed ID: 10973935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
